|
|
|
|
|
|
|
By Louis Garguilo, chief editor, Outsourced Pharma | “I assist C-suite executives to transfer quality from a painful cost center to a competitive asset." It's the type of bold statement that draws one's attention. Chief Editor Louis Garguilo asked David Grote on what his assertion means materially – and how that’s applied to working with CDMOs. Here's their discussion that focuses on a transformation that moves executives from regarding quality as ‘overhead’ to recognizing quality as “an operational element for business advantage.” | |
|
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
| The Fourth Industrial Revolution: Robotics And The Laboratory | Article | By Marc Brown, Ph.D. and Jon Lenn, Ph.D., MedPharm | Integration of robotics and automated systems across laboratory services significantly decreases experimental timelines, tightens precision, and enhances scientists' capacity for critical thinking. |
|
|
|
|
|
|
|
OUTSOURCED PHARMA CAPABILITIES UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capabilities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
| Connect With Outsourced Pharma: |
|
|
|
